TEXAS HEALTH KAUFMAN — History
CCN 450292 | 3-year financial timeline | COVID resilience: 77/100
🛡️ Public data only — no PHI permitted on this instance.
$45M
Latest Revenue (FY2022)
+20.7%
Revenue CAGR (3yr)
12.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $31M | $45M | $45M | -1.1% | +20.7% |
| Operating Expenses | $35M | $38M | $39M | +2.1% | +6.0% |
| Operating Margin | -13.3% | 15.4% | 12.6% | -17.9% | +0.0% |
| Net Income | $-4M | $7M | $6M | -18.8% | +0.0% |
| Licensed Beds | 46 | 42 | 42 | +0.0% | -4.4% |
| Total Patient Days | 3,307 | 4,363 | 2,701 | -38.1% | -9.6% |
| Medicare Day % | 31% | 21% | 26% | +23.8% | -8.4% |
| Medicaid Day % | 1% | 1% | 0% | -67.7% | -54.1% |
COVID Impact & Recovery
Resilience Score: 77/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +45.8% ($31M → $45M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+20.7%
This Hospital
+7.6%
State Avg
Latest Margin
12.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $52M | 25.6% |
| FY2024 (proj) | $59M | 38.6% |
| FY2025 (proj) | $66M | 51.5% |